Patricia D. Wilson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Urinary exosome proteomic profiling defines stage-specific rapid progression of autosomal dominant polycystic kidney disease and tolvaptan efficacy.
Journal: BBA advances
Published: January 15, 2021
Novel biomarkers in kidney disease: roles for cilia, Wnt signalling and ATMIN in polycystic kidney disease.
Journal: Biochemical Society transactions
Published: May 23, 2016
Therapeutic targets for polycystic kidney disease.
Journal: Expert opinion on therapeutic targets
Published: September 03, 2015
Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
Journal: PloS one
Published: October 18, 2013
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma.
Journal: British journal of cancer
Published: May 08, 2013
Retinoic acid receptor-dependent, cell-autonomous, endogenous retinoic acid signaling and its target genes in mouse collecting duct cells.
Journal: PloS one
Published: June 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026